DCLK2
Top inhibitors
| Drug | Inhibition % | Gini |
|---|---|---|
| Ceritinib | 77.7 | 0.62 |
| Lorlatinib | 69.7 | 0.69 |
| Crizotinib | 65.4 | 0.58 |
| Brigatinib | 60.0 | 0.51 |
| Baricitinib | 54.6 | 0.62 |
| Ruxolitinib | 44.4 | 0.59 |
| Abemaciclib | 34.5 | 0.56 |
| Fedratinib | 33.6 | 0.58 |
| Pemigatinib | 30.1 | 0.72 |
| Upadacitinib | 28.0 | 0.66 |
| Dabrafenib | 21.7 | 0.63 |
| Sunitinib | 19.4 | 0.52 |
| Neratinib | 17.2 | 0.60 |
| Palbociclib | 17.1 | 0.67 |
| Axitinib | 14.8 | 0.69 |
Known variants
No variants catalogued.